Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a notable player in the biotechnology sector, with a dedicated focus on developing treatments for rare and ultra-rare genetic diseases. Headquartered in Novato,..
For investors with a keen eye on the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents an intriguing opportunity. Despite facing challenges typical of clinical-stage biotech companies, Arcellx’s innovative approach and..
Investors looking for opportunities in the healthcare sector might find PROCEPT BioRobotics Corporation (NASDAQ: PRCT) a compelling prospect, especially given its projected upside potential of 61.91%. As a key player..
Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is making waves with its innovative approach to physician enablement. With a market capitalization of $2.88 billion,..
Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, has positioned itself as an intriguing investment opportunity within the healthcare sector. Headquartered in Boston, Massachusetts, Haemonetics stands..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a heavyweight in the dental equipment and healthcare consumables sector, presents a compelling case for investors who balance risk with income potential. Operating out of..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a notable player in the biotechnology sector, is capturing investor attention with its robust pipeline of treatments targeting central nervous system (CNS) disorders and rare..
iRhythm Technologies, Inc. (NASDAQ: IRTC), a leader in digital healthcare innovations, is making waves in the medical devices industry with its cutting-edge cardiac monitoring solutions. Known for its Zio platform,..
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector, focusing on pioneering treatments for rare genetic diseases. With a market capitalization of $2.5 billion, this Cambridge,..
ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its robust potential upside of 42.99%. The company, headquartered in..
Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the over-the-counter (OTC) health and personal care products sector, presents an intriguing opportunity for investors, with a potential upside of..
For investors with a keen eye on the healthcare sector, Bausch + Lomb Corporation (NYSE: BLCO) presents an intriguing opportunity. With a market capitalization of $6.1 billion, this Canadian-based company..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its promising advancements in treating rare neuroendocrine disorders. As a commercial-stage biopharmaceutical company based in Boston, Massachusetts,..
Investors eyeing the biotechnology sector should keep a close watch on Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company with promising prospects. As the company focuses on developing therapies for..
Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare plans sector, has emerged as an intriguing option for investors navigating the intricate landscape of healthcare technology. With a..
Vaxcyte, Inc. (PCVX), a company at the forefront of vaccine innovation, is capturing investor attention with its ambitious pipeline and significant stock potential. With a market capitalization of $6.03 billion,..
Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing investor attention with its strong growth trajectory and potential upside. Specializing in muscle activators and inhibitors, the..
RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, offers a compelling investment opportunity with a projected upside of 17.33%. As a leader in the Diagnostics & Research..
Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is captivating investors’ attention with its focus on developing innovative oncology treatments. With a market capitalization of $11.86 billion,..
Investors eyeing Medpace Holdings, Inc. (NASDAQ: MEDP) will find a healthcare powerhouse with impressive performance metrics and a robust market presence. Based in Cincinnati, Ohio, Medpace has carved out a..
